EMEA (Europe, Middle East and Africa) Parkinsons Disease Drugs Market Report 2017

Choose Licence

 

In this report, the EMEA Parkinsons Disease Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Parkinsons Disease Drugs for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Parkinsons Disease Drugs market competition by top manufacturers/players, with Parkinsons Disease Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie Merck Akorn Astellas Pharma Desitin Arzneimittel Endo Pharmaceuticals F.Hoffmann-La Roche H.Lundbeck Kyowa Hakko Kirin Pharma Orion Stada Arzneimittel Valeant Apokyn On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into Madopar Sinemet-CR Trastal COMT Inhibitor Other On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Parkinsons Disease Drugs for each application, including Hospital Clinic

 

Table of Contents EMEA (Europe, Middle East and Africa) Parkinsons Disease Drugs Market Report 2017 1 Parkinsons Disease Drugs Overview 1.1 Product Overview and Scope of Parkinsons Disease Drugs 1.2 Classification of Parkinsons Disease Drugs 1.2.1 EMEA Parkinsons Disease Drugs Market Size (Sales) Comparison by Type (2012-2022) 1.2.2 EMEA Parkinsons Disease Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 Madopar 1.2.4 Sinemet-CR 1.2.5 Trastal 1.2.6 COMT Inhibitor 1.2.7 Other 1.3 EMEA Parkinsons Disease Drugs Market by Application/End Users 1.3.1 EMEA Parkinsons Disease Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022 1.3.2 Hospital 1.3.3 Clinic 1.4 EMEA Parkinsons Disease Drugs Market by Region 1.4.1 EMEA Parkinsons Disease Drugs Market Size (Value) Comparison by Region (2012-2022) 1.4.2 Europe Status and Prospect (2012-2022) 1.4.3 Middle East Status and Prospect (2012-2022) 1.4.4 Africa Status and Prospect (2012-2022) 1.5 EMEA Market Size (Value and Volume) of Parkinsons Disease Drugs (2012-2022) 1.5.1 EMEA Parkinsons Disease Drugs Sales and Growth Rate (2012-2022) 1.5.2 EMEA Parkinsons Disease Drugs Revenue and Growth Rate (2012-2022) 2 EMEA Parkinsons Disease Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application 2.1 EMEA Parkinsons Disease Drugs Market Competition by Players/Manufacturers 2.1.1 EMEA Parkinsons Disease Drugs Sales Volume and Market Share of Major Players (2012-2017) 2.1.2 EMEA Parkinsons Disease Drugs Revenue and Share by Players (2012-2017) 2.1.3 EMEA Parkinsons Disease Drugs Sale Price by Players (2012-2017) 2.2 EMEA Parkinsons Disease Drugs (Volume and Value) by Type/Product Category 2.2.1 EMEA Parkinsons Disease Drugs Sales and Market Share by Type (2012-2017) 2.2.2 EMEA Parkinsons Disease Drugs Revenue and Market Share by Type (2012-2017) 2.2.3 EMEA Parkinsons Disease Drugs Sale Price by Type (2012-2017) 2.3 EMEA Parkinsons Disease Drugs (Volume) by Application 2.4 EMEA Parkinsons Disease Drugs (Volume and Value) by Region 2.4.1 EMEA Parkinsons Disease Drugs Sales and Market Share by Region (2012-2017) 2.4.2 EMEA Parkinsons Disease Drugs Revenue and Market Share by Region (2012-2017) 2.4.3 EMEA Parkinsons Disease Drugs Sales Price by Region (2012-2017) 3 Europe Parkinsons Disease Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application 3.1 Europe Parkinsons Disease Drugs Sales and Value (2012-2017) 3.1.1 Europe Parkinsons Disease Drugs Sales Volume and Growth Rate (2012-2017) 3.1.2 Europe Parkinsons Disease Drugs Revenue and Growth Rate (2012-2017) 3.2 Europe Parkinsons Disease Drugs Sales and Market Share by Type 3.3 Europe Parkinsons Disease Drugs Sales and Market Share by Application 3.4 Europe Parkinsons Disease Drugs Sales Volume and Value (Revenue) by Countries 3.4.1 Europe Parkinsons Disease Drugs Sales Volume by Countries (2012-2017) 3.4.2 Europe Parkinsons Disease Drugs Revenue by Countries (2012-2017) 3.4.3 Germany Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 3.4.4 France Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 3.4.5 UK Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 3.4.6 Russia Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 3.4.7 Italy Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 3.4.8 Benelux Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 4 Middle East Parkinsons Disease Drugs (Volume, Value and Sales Price), by Region, Type and Application 4.1 Middle East Parkinsons Disease Drugs Sales and Value (2012-2017) 4.1.1 Middle East Parkinsons Disease Drugs Sales Volume and Growth Rate (2012-2017) 4.1.2 Middle East Parkinsons Disease Drugs Revenue and Growth Rate (2012-2017) 4.2 Middle East Parkinsons Disease Drugs Sales and Market Share by Type 4.3 Middle East Parkinsons Disease Drugs Sales and Market Share by Application 4.4 Middle East Parkinsons Disease Drugs Sales Volume and Value (Revenue) by Countries 4.4.1 Middle East Parkinsons Disease Drugs Sales Volume by Countries (2012-2017) 4.4.2 Middle East Parkinsons Disease Drugs Revenue by Countries (2012-2017) 4.4.3 Saudi Arabia Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 4.4.4 Israel Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 4.4.5 UAE Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 4.4.6 Iran Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 5 Africa Parkinsons Disease Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application 5.1 Africa Parkinsons Disease Drugs Sales and Value (2012-2017) 5.1.1 Africa Parkinsons Disease Drugs Sales Volume and Growth Rate (2012-2017) 5.1.2 Africa Parkinsons Disease Drugs Revenue and Growth Rate (2012-2017) 5.2 Africa Parkinsons Disease Drugs Sales and Market Share by Type 5.3 Africa Parkinsons Disease Drugs Sales and Market Share by Application 5.4 Africa Parkinsons Disease Drugs Sales Volume and Value (Revenue) by Countries 5.4.1 Africa Parkinsons Disease Drugs Sales Volume by Countries (2012-2017) 5.4.2 Africa Parkinsons Disease Drugs Revenue by Countries (2012-2017) 5.4.3 South Africa Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 5.4.4 Nigeria Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 5.4.5 Egypt Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 5.4.6 Algeria Parkinsons Disease Drugs Sales and Growth Rate (2012-2017) 6 EMEA Parkinsons Disease Drugs Manufacturers/Players Profiles and Sales Data 6.1 GSK 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Parkinsons Disease Drugs Product Type, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 GSK Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 Novartis 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Parkinsons Disease Drugs Product Type, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Novartis Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview 6.3 Boehringer Ingelheim 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Parkinsons Disease Drugs Product Type, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Boehringer Ingelheim Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Main Business/Business Overview 6.4 Teva Pharmaceutical 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Parkinsons Disease Drugs Product Type, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Teva Pharmaceutical Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Main Business/Business Overview 6.5 Abbvie 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Parkinsons Disease Drugs Product Type, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Abbvie Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Main Business/Business Overview 6.6 Merck 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Parkinsons Disease Drugs Product Type, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Merck Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Main Business/Business Overview 6.7 Akorn 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Parkinsons Disease Drugs Product Type, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Akorn Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Main Business/Business Overview 6.8 Astellas Pharma 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Parkinsons Disease Drugs Product Type, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Astellas Pharma Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 6.8.4 Main Business/Business Overview 6.9 Desitin Arzneimittel 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Parkinsons Disease Drugs Product Type, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Desitin Arzneimittel Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Main Business/Business Overview 6.10 Endo Pharmaceuticals 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Parkinsons Disease Drugs Product Type, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Endo Pharmaceuticals Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 6.10.4 Main Business/Business Overview 6.11 F.Hoffmann-La Roche 6.12 H.Lundbeck 6.13 Kyowa Hakko Kirin Pharma 6.14 Orion 6.15 Stada Arzneimittel 6.16 Valeant 6.17 Apokyn 7 Parkinsons Disease Drugs Manufacturing Cost Analysis 7.1 Parkinsons Disease Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Parkinsons Disease Drugs 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Parkinsons Disease Drugs Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Parkinsons Disease Drugs Major Manufacturers in 2016 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 EMEA Parkinsons Disease Drugs Market Forecast (2017-2022) 11.1 EMEA Parkinsons Disease Drugs Sales, Revenue and Price Forecast (2017-2022) 11.1.1 EMEA Parkinsons Disease Drugs Sales and Growth Rate Forecast (2017-2022) 11.1.2 EMEA Parkinsons Disease Drugs Revenue and Growth Rate Forecast (2017-2022) 11.1.3 EMEA Parkinsons Disease Drugs Price and Trend Forecast (2017-2022) 11.2 EMEA Parkinsons Disease Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.3 Europe Parkinsons Disease Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.4 Middle Eastt Parkinsons Disease Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.5 Africa Parkinsons Disease Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.6 EMEA Parkinsons Disease Drugs Sales Forecast by Type (2017-2022) 11.7 EMEA Parkinsons Disease Drugs Sales Forecast by Application (2017-2022) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Parkinsons Disease Drugs Figure EMEA Parkinsons Disease Drugs Sales Volume (K Pcs) by Type (2012-2022) Figure EMEA Parkinsons Disease Drugs Sales Volume Market Share by Type (Product Category) in 2016 Figure Madopar Product Picture Figure Sinemet-CR Product Picture Figure Trastal Product Picture Figure COMT Inhibitor Product Picture Figure Other Product Picture Figure EMEA Parkinsons Disease Drugs Sales Volume (K Pcs) by Application (2012-2022) Figure EMEA Sales Market Share of Parkinsons Disease Drugs by Application in 2016 Figure Hospital Examples Figure Clinic Examples Figure EMEA Parkinsons Disease Drugs Market Size (Million USD) by Region (2012-2022) Figure Europe Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure Europe Parkinsons Disease Drugs Revenue (Million USD) Status and Forecast by Countries Figure Middle East Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure Middle East Parkinsons Disease Drugs Revenue (Million USD) Status and Forecast by Countries Figure Africa Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure Africa Parkinsons Disease Drugs Revenue (Million USD) Status and Forecast by Countries Figure EMEA Parkinsons Disease Drugs Sales Volume and Growth Rate (2012-2022) Figure EMEA Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure EMEA Parkinsons Disease Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017) Table EMEA Parkinsons Disease Drugs Sales Volume (K Pcs) of Major Players (2012-2017) Table EMEA Parkinsons Disease Drugs Sales Share by Players (2012-2017) Figure 2016 Parkinsons Disease Drugs Sales Share by Players Figure 2017 Parkinsons Disease Drugs Sales Share by Players Figure EMEA Parkinsons Disease Drugs Market Major Players Product Revenue (Million USD) (2012-2017) Table EMEA Parkinsons Disease Drugs Revenue (Million USD) by Players (2012-2017) Table EMEA Parkinsons Disease Drugs Revenue Share by Players (2012-2017) Table 2016 EMEA Parkinsons Disease Drugs Revenue Share by Players Table 2017 EMEA Parkinsons Disease Drugs Revenue Share by Players Table EMEA Parkinsons Disease Drugs Sale Price (USD/Pcs) by Players (2012-2017) Table EMEA Parkinsons Disease Drugs Sales (K Pcs) and Market Share by Type (2012-2017) Table EMEA Parkinsons Disease Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Parkinsons Disease Drugs by Type (2012-2017) Figure EMEA Parkinsons Disease Drugs Sales Market Share by Type (2012-2017) Table EMEA Parkinsons Disease Drugs Revenue (Million USD) and Market Share by Type (2012-2017) Table EMEA Parkinsons Disease Drugs Revenue Share by Type (2012-2017) Figure Revenue Market Share of Parkinsons Disease Drugs by Type in 2016 Table EMEA Parkinsons Disease Drugs Sale Price (USD/Pcs) by Type (2012-2017) Table EMEA Parkinsons Disease Drugs Sales (K Pcs) and Market Share by Application (2012-2017) Table EMEA Parkinsons Disease Drugs Sales Share by Application (2012-2017) Figure Sales Market Share of Parkinsons Disease Drugs by Application (2012-2017) Figure EMEA Parkinsons Disease Drugs Sales Market Share by Application in 2016 Table EMEA Parkinsons Disease Drugs Sales (K Pcs) and Market Share by Region (2012-2017) Table EMEA Parkinsons Disease Drugs Sales Share by Region (2012-2017) Figure Sales Market Share of Parkinsons Disease Drugs by Region (2012-2017) Figure EMEA Parkinsons Disease Drugs Sales Market Share in 2016 Table EMEA Parkinsons Disease Drugs Revenue (Million USD) and Market Share by Region (2012-2017) Table EMEA Parkinsons Disease Drugs Revenue Share by Region (2012-2017) Figure Revenue Market Share of Parkinsons Disease Drugs by Region (2012-2017) Figure EMEA Parkinsons Disease Drugs Revenue Market Share Regions in 2016 Table EMEA Parkinsons Disease Drugs Sales Price (USD/Pcs) by Region (2012-2017) Figure Europe Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Europe Parkinsons Disease Drugs Revenue and Growth Rate (2012-2017) Table Europe Parkinsons Disease Drugs Sales (K Pcs) by Type (2012-2017) Table Europe Parkinsons Disease Drugs Market Share by Type (2012-2017) Figure Europe Parkinsons Disease Drugs Market Share by Type in 2016 Table Europe Parkinsons Disease Drugs Sales (K Pcs) by Application (2012-2017) Table Europe Parkinsons Disease Drugs Market Share by Application (2012-2017) Figure Europe Parkinsons Disease Drugs Market Share by Application in 2016 Table Europe Parkinsons Disease Drugs Sales (K Pcs) by Countries (2012-2017) Table Europe Parkinsons Disease Drugs Sales Market Share by Countries (2012-2017) Figure Europe Parkinsons Disease Drugs Sales Market Share by Countries (2012-2017) Figure Europe Parkinsons Disease Drugs Sales Market Share by Countries in 2016 Table Europe Parkinsons Disease Drugs Revenue (Million USD) by Countries (2012-2017) Table Europe Parkinsons Disease Drugs Revenue Market Share by Countries (2012-2017) Figure Europe Parkinsons Disease Drugs Revenue Market Share by Countries (2012-2017) Figure Europe Parkinsons Disease Drugs Revenue Market Share by Countries in 2016 Figure Germany Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure France Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure UK Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Russia Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Italy Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Benelux Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Middle East Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Middle East Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2012-2017) Table Middle East Parkinsons Disease Drugs Sales (K Pcs) by Type (2012-2017) Table Middle East Parkinsons Disease Drugs Market Share by Type (2012-2017) Figure Middle East Parkinsons Disease Drugs Market Share by Type (2012-2017) Table Middle East Parkinsons Disease Drugs Sales (K Pcs) by Applications (2012-2017) Table Middle East Parkinsons Disease Drugs Market Share by Applications (2012-2017) Figure Middle East Parkinsons Disease Drugs Sales Market Share by Application in 2016 Table Middle East Parkinsons Disease Drugs Sales Volume (K Pcs) by Countries (2012-2017) Table Middle East Parkinsons Disease Drugs Sales Volume Market Share by Countries (2012-2017) Figure Middle East Parkinsons Disease Drugs Sales Volume Market Share by Countries in 2016 Table Middle East Parkinsons Disease Drugs Revenue (Million USD) by Countries (2012-2017) Table Middle East Parkinsons Disease Drugs Revenue Market Share by Countries (2012-2017) Figure Middle East Parkinsons Disease Drugs Revenue Market Share by Countries (2012-2017) Figure Middle East Parkinsons Disease Drugs Revenue Market Share by Countries in 2016 Figure Saudi Arabia Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Israel Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure UAE Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Iran Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Africa Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Africa Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2012-2017) Table Africa Parkinsons Disease Drugs Sales (K Pcs) by Type (2012-2017) Table Africa Parkinsons Disease Drugs Sales Market Share by Type (2012-2017) Figure Africa Parkinsons Disease Drugs Sales Market Share by Type (2012-2017) Figure Africa Parkinsons Disease Drugs Sales Market Share by Type in 2016 Table Africa Parkinsons Disease Drugs Sales (K Pcs) by Application (2012-2017) Table Africa Parkinsons Disease Drugs Sales Market Share by Application (2012-2017) Figure Africa Parkinsons Disease Drugs Sales Market Share by Application (2012-2017) Table Africa Parkinsons Disease Drugs Sales Volume (K Pcs) by Countries (2012-2017) Table Africa Parkinsons Disease Drugs Sales Market Share by Countries (2012-2017) Figure Africa Parkinsons Disease Drugs Sales Market Share by Countries (2012-2017) Figure Africa Parkinsons Disease Drugs Sales Market Share by Countries in 2016 Table Africa Parkinsons Disease Drugs Revenue (Million USD) by Countries (2012-2017) Table Africa Parkinsons Disease Drugs Revenue Market Share by Countries (2012-2017) Figure Africa Parkinsons Disease Drugs Revenue Market Share by Countries (2012-2017) Figure Africa Parkinsons Disease Drugs Revenue Market Share by Countries in 2016 Figure South Africa Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Nigeria Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Egypt Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Algeria Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Table GSK Parkinsons Disease Drugs Basic Information List Table GSK Parkinsons Disease Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure GSK Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure GSK Parkinsons Disease Drugs Sales Market Share in EMEA (2012-2017) Figure GSK Parkinsons Disease Drugs Revenue Market Share in EMEA (2012-2017) Table Novartis Parkinsons Disease Drugs Basic Information List Table Novartis Parkinsons Disease Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Novartis Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Novartis Parkinsons Disease Drugs Sales Market Share in EMEA (2012-2017) Figure Novartis Parkinsons Disease Drugs Revenue Market Share in EMEA (2012-2017) Table Boehringer Ingelheim Parkinsons Disease Drugs Basic Information List Table Boehringer Ingelheim Parkinsons Disease Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Boehringer Ingelheim Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Boehringer Ingelheim Parkinsons Disease Drugs Sales Market Share in EMEA (2012-2017) Figure Boehringer Ingelheim Parkinsons Disease Drugs Revenue Market Share in EMEA (2012-2017) Table Teva Pharmaceutical Parkinsons Disease Drugs Basic Information List Table Teva Pharmaceutical Parkinsons Disease Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Teva Pharmaceutical Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Teva Pharmaceutical Parkinsons Disease Drugs Sales Market Share in EMEA (2012-2017) Figure Teva Pharmaceutical Parkinsons Disease Drugs Revenue Market Share in EMEA (2012-2017) Table Abbvie Parkinsons Disease Drugs Basic Information List Table Abbvie Parkinsons Disease Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Abbvie Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Abbvie Parkinsons Disease Drugs Sales Market Share in EMEA (2012-2017) Figure Abbvie Parkinsons Disease Drugs Revenue Market Share in EMEA (2012-2017) Table Merck Parkinsons Disease Drugs Basic Information List Table Merck Parkinsons Disease Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Merck Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Merck Parkinsons Disease Drugs Sales Market Share in EMEA (2012-2017) Figure Merck Parkinsons Disease Drugs Revenue Market Share in EMEA (2012-2017) Table Akorn Parkinsons Disease Drugs Basic Information List Table Akorn Parkinsons Disease Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Akorn Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Akorn Parkinsons Disease Drugs Sales Market Share in EMEA (2012-2017) Figure Akorn Parkinsons Disease Drugs Revenue Market Share in EMEA (2012-2017) Table Astellas Pharma Parkinsons Disease Drugs Basic Information List Table Astellas Pharma Parkinsons Disease Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Astellas Pharma Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Astellas Pharma Parkinsons Disease Drugs Sales Market Share in EMEA (2012-2017) Figure Astellas Pharma Parkinsons Disease Drugs Revenue Market Share in EMEA (2012-2017) Table Desitin Arzneimittel Parkinsons Disease Drugs Basic Information List Table Desitin Arzneimittel Parkinsons Disease Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Desitin Arzneimittel Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Desitin Arzneimittel Parkinsons Disease Drugs Sales Market Share in EMEA (2012-2017) Figure Desitin Arzneimittel Parkinsons Disease Drugs Revenue Market Share in EMEA (2012-2017) Table Endo Pharmaceuticals Parkinsons Disease Drugs Basic Information List Table Endo Pharmaceuticals Parkinsons Disease Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Endo Pharmaceuticals Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate (2012-2017) Figure Endo Pharmaceuticals Parkinsons Disease Drugs Sales Market Share in EMEA (2012-2017) Figure Endo Pharmaceuticals Parkinsons Disease Drugs Revenue Market Share in EMEA (2012-2017) Table F.Hoffmann-La Roche Parkinsons Disease Drugs Basic Information List Table H.Lundbeck Parkinsons Disease Drugs Basic Information List Table Kyowa Hakko Kirin Pharma Parkinsons Disease Drugs Basic Information List Table Orion Parkinsons Disease Drugs Basic Information List Table Stada Arzneimittel Parkinsons Disease Drugs Basic Information List Table Valeant Parkinsons Disease Drugs Basic Information List Table Apokyn Parkinsons Disease Drugs Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Parkinsons Disease Drugs Figure Manufacturing Process Analysis of Parkinsons Disease Drugs Figure Parkinsons Disease Drugs Industrial Chain Analysis Table Raw Materials Sources of Parkinsons Disease Drugs Major Manufacturers in 2016 Table Major Buyers of Parkinsons Disease Drugs Table Distributors/Traders List Figure EMEA Parkinsons Disease Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022) Figure EMEA Parkinsons Disease Drugs Revenue and Growth Rate Forecast (2017-2022) Figure EMEA Parkinsons Disease Drugs Price (USD/Pcs) and Trend Forecast (2017-2022) Table EMEA Parkinsons Disease Drugs Sales (K Pcs) Forecast by Region (2017-2022) Figure EMEA Parkinsons Disease Drugs Sales Market Share Forecast by Region (2017-2022) Table EMEA Parkinsons Disease Drugs Revenue (Million USD) Forecast by Region (2017-2022) Figure EMEA Parkinsons Disease Drugs Revenue Market Share Forecast by Region (2017-2022) Table Europe Parkinsons Disease Drugs Sales (K Pcs) Forecast by Countries (2017-2022) Figure Europe Parkinsons Disease Drugs Sales Market Share Forecast by Countries (2017-2022) Table Europe Parkinsons Disease Drugs Revenue (Million USD) Forecast by Countries (2017-2022) Figure Europe Parkinsons Disease Drugs Revenue Market Share Forecast by Countries (2017-2022) Table Middle East Parkinsons Disease Drugs Sales (K Pcs) Forecast by Countries (2017-2022) Figure Middle East Parkinsons Disease Drugs Sales Market Share Forecast by Countries (2017-2022) Table Middle East Parkinsons Disease Drugs Revenue (Million USD) Forecast by Countries (2017-2022) Figure Middle East Parkinsons Disease Drugs Revenue Market Share Forecast by Countries (2017-2022) Table Africa Parkinsons Disease Drugs Sales (K Pcs) Forecast by Countries (2017-2022) Figure Africa Parkinsons Disease Drugs Sales Market Share Forecast by Countries (2017-2022) Table Africa Parkinsons Disease Drugs Revenue (Million USD) Forecast by Countries (2017-2022) Figure Africa Parkinsons Disease Drugs Revenue Market Share Forecast by Countries (2017-2022) Table EMEA Parkinsons Disease Drugs Sales (K Pcs) Forecast by Type (2017-2022) Figure EMEA Parkinsons Disease Drugs Sales Market Share Forecast by Type (2017-2022) Table EMEA Parkinsons Disease Drugs Sales (K Pcs) Forecast by Application (2017-2022) Figure EMEA Parkinsons Disease Drugs Sales Market Share Forecast by Application (2017-2022) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Bio-Detection Market Professional Survey Report 2018

This report studies the global Bio-Detection market status and forecast, categorizes the global Bio-Detection market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America,...

Global Biochemistry Analyzer Market Professional Survey Report 2018

This report studies the global Biochemistry Analyzer market status and forecast, categorizes the global Biochemistry Analyzer market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers i...

Global Bio-based Solvent Market Professional Survey Report 2018

This report studies the global Bio-based Solvent market status and forecast, categorizes the global Bio-based Solvent market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North ...

Global Bio-Based Resins Market Professional Survey Report 2018

This report studies the global Bio-Based Resins market status and forecast, categorizes the global Bio-Based Resins market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North Am...

Global Bio-based Propylene Glycol Market Professional Survey Report 2018

This report studies the global Bio-based Propylene Glycol market status and forecast, categorizes the global Bio-based Propylene Glycol market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manuf...

New Pharmaceuticals and Healthcare Reports